Mirna Therapeutics, Inc. Announces Dr. David Johnson as Scientific Advisor

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (“Mirna”) announced today that David Johnson, M.D., F.A.C.P., of UT Southwestern in Dallas, has joined the Company as Scientific Advisor.

MORE ON THIS TOPIC